Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Nov 1;100(9):2286–2294. doi: 10.1172/JCI119766

Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype.

P W Cook 1, M Piepkorn 1, C H Clegg 1, G D Plowman 1, J M DeMay 1, J R Brown 1, M R Pittelkow 1
PMCID: PMC508424  PMID: 9410906

Abstract

Amphiregulin (AR) is a heparin-binding, heparin-inhibited member of the epidermal growth factor (EGF) family and an autocrine growth factor for human keratinocytes. Previous studies have shown that AR expression is increased in psoriatic epidermis. To test the hypothesis that aberrant AR expression is central to the development of psoriatic lesions, we constructed a transgene (K14-ARGE) encoding a human keratin 14 promoter-driven AR gene. Our results indicate that transgene integration and subsequent expression of AR in basal keratinocytes correlated with a psoriasis-like skin phenotype. Afflicted mice demonstrated shortened life spans, prominent scaling and erythematous skin with alopecia, and occasional papillomatous epidermal growths. Histologic examination revealed extensive areas of marked hyperkeratosis with focal parakeratosis, acanthosis, dermal and epidermal lymphocytic and neutrophilic infiltration, and dilated blood vessels within the papillary dermis. Our results reveal that AR exerts activity in the skin that is distinct from that of transgenic transforming growth factor-alpha or other cytokines, and induces skin pathology with striking similarities to psoriasis. Our observations also link the keratinocyte EGF receptor-ligand system to psoriatic inflammation, and suggest that aberrant expression of AR in the epidermis may represent a critical step in the development or propagation of psoriatic lesions.

Full Text

The Full Text of this article is available as a PDF (714.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bata-Csorgo Z., Hammerberg C., Voorhees J. J., Cooper K. D. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest. 1995 Jan;95(1):317–327. doi: 10.1172/JCI117659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blessing M., Schirmacher P., Kaiser S. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol. 1996 Oct;135(1):227–239. doi: 10.1083/jcb.135.1.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Byrne C., Tainsky M., Fuchs E. Programming gene expression in developing epidermis. Development. 1994 Sep;120(9):2369–2383. doi: 10.1242/dev.120.9.2369. [DOI] [PubMed] [Google Scholar]
  4. Carroll J. M., Crompton T., Seery J. P., Watt F. M. Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invest Dermatol. 1997 Apr;108(4):412–422. doi: 10.1111/1523-1747.ep12289702. [DOI] [PubMed] [Google Scholar]
  5. Carroll J. M., Romero M. R., Watt F. M. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell. 1995 Dec 15;83(6):957–968. doi: 10.1016/0092-8674(95)90211-2. [DOI] [PubMed] [Google Scholar]
  6. Cheng J., Turksen K., Yu Q. C., Schreiber H., Teng M., Fuchs E. Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice. Genes Dev. 1992 Aug;6(8):1444–1456. doi: 10.1101/gad.6.8.1444. [DOI] [PubMed] [Google Scholar]
  7. Cook P. W., Ashton N. M., Karkaria C. E., Siess D. C., Shipley G. D. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity. J Cell Physiol. 1995 May;163(2):418–429. doi: 10.1002/jcp.1041630222. [DOI] [PubMed] [Google Scholar]
  8. Cook P. W., Damm D., Garrick B. L., Wood K. M., Karkaria C. E., Higashiyama S., Klagsbrun M., Abraham J. A. Carboxyl-terminal truncation of leucine76 converts heparin-binding EGF-like growth factor from a heparin-enhancible to a heparin-suppressible growth factor. J Cell Physiol. 1995 May;163(2):407–417. doi: 10.1002/jcp.1041630221. [DOI] [PubMed] [Google Scholar]
  9. Cook P. W., Mattox P. A., Keeble W. W., Pittelkow M. R., Plowman G. D., Shoyab M., Adelman J. P., Shipley G. D. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol Cell Biol. 1991 May;11(5):2547–2557. doi: 10.1128/mcb.11.5.2547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cook P. W., Mattox P. A., Keeble W. W., Shipley G. D. Inhibition of autonomous human keratinocyte proliferation and amphiregulin mitogenic activity by sulfated polysaccharides. In Vitro Cell Dev Biol. 1992 Mar;28A(3 Pt 1):218–222. doi: 10.1007/BF02631096. [DOI] [PubMed] [Google Scholar]
  11. Cook P. W., Pittelkow M. R., Keeble W. W., Graves-Deal R., Coffey R. J., Jr, Shipley G. D. Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res. 1992 Jun 1;52(11):3224–3227. [PubMed] [Google Scholar]
  12. Cook P. W., Pittelkow M. R., Shipley G. D. Growth factor-independent proliferation of normal human neonatal keratinocytes: production of autocrine- and paracrine-acting mitogenic factors. J Cell Physiol. 1991 Feb;146(2):277–289. doi: 10.1002/jcp.1041460213. [DOI] [PubMed] [Google Scholar]
  13. Coulombe P. A., Kopan R., Fuchs E. Expression of keratin K14 in the epidermis and hair follicle: insights into complex programs of differentiation. J Cell Biol. 1989 Nov;109(5):2295–2312. doi: 10.1083/jcb.109.5.2295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dominey A. M., Wang X. J., King L. E., Jr, Nanney L. B., Gagne T. A., Sellheyer K., Bundman D. S., Longley M. A., Rothnagel J. A., Greenhalgh D. A. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ. 1993 Dec;4(12):1071–1082. [PubMed] [Google Scholar]
  15. Elder J. T., Fisher G. J., Lindquist P. B., Bennett G. L., Pittelkow M. R., Coffey R. J., Jr, Ellingsworth L., Derynck R., Voorhees J. J. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science. 1989 Feb 10;243(4892):811–814. doi: 10.1126/science.2916128. [DOI] [PubMed] [Google Scholar]
  16. Gardembas-Pain M., Ifrah N., Foussard C., Boasson M., Saint Andre J. P., Verret J. L. Psoriasis after allogeneic bone marrow transplantation. Arch Dermatol. 1990 Nov;126(11):1523–1523. doi: 10.1001/archderm.1990.01670350139033. [DOI] [PubMed] [Google Scholar]
  17. Gottlieb S. L., Gilleaudeau P., Johnson R., Estes L., Woodworth T. G., Gottlieb A. B., Krueger J. G. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med. 1995 May;1(5):442–447. doi: 10.1038/nm0595-442. [DOI] [PubMed] [Google Scholar]
  18. Groves R. W., Mizutani H., Kieffer J. D., Kupper T. S. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11874–11878. doi: 10.1073/pnas.92.25.11874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Groves R. W., Rauschmayr T., Nakamura K., Sarkar S., Williams I. R., Kupper T. S. Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J Clin Invest. 1996 Jul 15;98(2):336–344. doi: 10.1172/JCI118797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Guo L., Yu Q. C., Fuchs E. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J. 1993 Mar;12(3):973–986. doi: 10.1002/j.1460-2075.1993.tb05738.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hashimoto K., Higashiyama S., Asada H., Hashimura E., Kobayashi T., Sudo K., Nakagawa T., Damm D., Yoshikawa K., Taniguchi N. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem. 1994 Aug 5;269(31):20060–20066. [PubMed] [Google Scholar]
  22. Headington J. T., Gupta A. K., Goldfarb M. T., Nickoloff B. J., Hamilton T. A., Ellis C. N., Voorhees J. J. A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia. Arch Dermatol. 1989 May;125(5):639–642. [PubMed] [Google Scholar]
  23. Higashiyama S., Lau K., Besner G. E., Abraham J. A., Klagsbrun M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem. 1992 Mar 25;267(9):6205–6212. [PubMed] [Google Scholar]
  24. Jeffes E. W., 3rd, McCullough J. L., Pittelkow M. R., McCormick A., Almanzor J., Liu G., Dang M., Voss K., Voss J., Schlotzhauer A. Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate. J Invest Dermatol. 1995 Feb;104(2):183–188. doi: 10.1111/1523-1747.ep12612745. [DOI] [PubMed] [Google Scholar]
  25. Jegasothy B. V., Ackerman C. D., Todo S., Fung J. J., Abu-Elmagd K., Starzl T. E. Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol. 1992 Jun;128(6):781–785. [PMC free article] [PubMed] [Google Scholar]
  26. Johnson G. R., Saeki T., Auersperg N., Gordon A. W., Shoyab M., Salomon D. S., Stromberg K. Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: nuclear localization of endogenous amphiregulin. Biochem Biophys Res Commun. 1991 Oct 31;180(2):481–488. doi: 10.1016/s0006-291x(05)81090-3. [DOI] [PubMed] [Google Scholar]
  27. Kimura H. Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2165–2169. doi: 10.1073/pnas.90.6.2165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. King L. E., Jr, Gates R. E., Stoscheck C. M., Nanney L. B. Epidermal growth factor/transforming growth factor alpha receptors and psoriasis. J Invest Dermatol. 1990 Nov;95(5 Suppl):10S–12S. doi: 10.1111/1523-1747.ep12505661. [DOI] [PubMed] [Google Scholar]
  29. Koo J., Nguyen Q., Gambla C. Advances in psoriasis therapy. Adv Dermatol. 1997;12:47–73. [PubMed] [Google Scholar]
  30. Lebwohl M., Abel E., Zanolli M., Koo J., Drake L. Topical therapy for psoriasis. Int J Dermatol. 1995 Oct;34(10):673–684. [PubMed] [Google Scholar]
  31. Lim K. K., Su W. P., Schroeter A. L., Sabers C. J., Abraham R. T., Pittelkow M. R. Cyclosporine in the treatment of dermatologic disease: an update. Mayo Clin Proc. 1996 Dec;71(12):1182–1191. doi: 10.4065/71.12.1182. [DOI] [PubMed] [Google Scholar]
  32. Liou A., Elias P. M., Grunfeld C., Feingold K. R., Wood L. C. Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis. J Invest Dermatol. 1997 Jan;108(1):73–77. doi: 10.1111/1523-1747.ep12285638. [DOI] [PubMed] [Google Scholar]
  33. Marikovsky M., Breuing K., Liu P. Y., Eriksson E., Higashiyama S., Farber P., Abraham J., Klagsbrun M. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci U S A. 1993 May 1;90(9):3889–3893. doi: 10.1073/pnas.90.9.3889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nanney L. B., Yates R. A., King L. E., Jr Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF. J Invest Dermatol. 1992 Mar;98(3):296–301. doi: 10.1111/1523-1747.ep12497963. [DOI] [PubMed] [Google Scholar]
  35. Philpott M. P., Sanders D., Westgate G. E., Kealey T. Human hair growth in vitro: a model for the study of hair follicle biology. J Dermatol Sci. 1994 Jul;7 (Suppl):S55–S72. doi: 10.1016/0923-1811(94)90036-1. [DOI] [PubMed] [Google Scholar]
  36. Piepkorn M., Lo C., Plowman G. Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J Cell Physiol. 1994 Apr;159(1):114–120. doi: 10.1002/jcp.1041590115. [DOI] [PubMed] [Google Scholar]
  37. Piepkorn M. Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases. Am J Dermatopathol. 1996 Apr;18(2):165–171. doi: 10.1097/00000372-199604000-00010. [DOI] [PubMed] [Google Scholar]
  38. Piepkorn M., Underwood R. A., Henneman C., Smith L. T. Expression of amphiregulin is regulated in cultured human keratinocytes and in developing fetal skin. J Invest Dermatol. 1995 Dec;105(6):802–809. doi: 10.1111/1523-1747.ep12326567. [DOI] [PubMed] [Google Scholar]
  39. Pittelkow M. R., Cook P. W., Shipley G. D., Derynck R., Coffey R. J., Jr Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy. Cell Growth Differ. 1993 Jun;4(6):513–521. [PubMed] [Google Scholar]
  40. Plowman G. D., Green J. M., McDonald V. L., Neubauer M. G., Disteche C. M., Todaro G. J., Shoyab M. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol. 1990 May;10(5):1969–1981. doi: 10.1128/mcb.10.5.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Runne U., Kroneisen-Wiersma P. Psoriatic alopecia: acute and chronic hair loss in 47 patients with scalp psoriasis. Dermatology. 1992;185(2):82–87. doi: 10.1159/000247418. [DOI] [PubMed] [Google Scholar]
  42. Runne U., Kroneisen P. Alopecia psoriatica Manifestation, Verlauf und Therapie bei 34 Patienten. Z Hautkr. 1989 Apr 15;64(4):302-4, 307-10, 313-4. [PubMed] [Google Scholar]
  43. Schoorl W. J., van Baar H. J., van de Kerkhof P. C. The hair root pattern in psoriasis of the scalp. Acta Derm Venereol. 1992;72(2):141–142. [PubMed] [Google Scholar]
  44. Schön M. P., Detmar M., Parker C. M. Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat Med. 1997 Feb;3(2):183–188. doi: 10.1038/nm0297-183. [DOI] [PubMed] [Google Scholar]
  45. Shipley G. D., Keeble W. W., Hendrickson J. E., Coffey R. J., Jr, Pittelkow M. R. Growth of normal human keratinocytes and fibroblasts in serum-free medium is stimulated by acidic and basic fibroblast growth factor. J Cell Physiol. 1989 Mar;138(3):511–518. doi: 10.1002/jcp.1041380310. [DOI] [PubMed] [Google Scholar]
  46. Shoyab M., McDonald V. L., Bradley J. G., Todaro G. J. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6528–6532. doi: 10.1073/pnas.85.17.6528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Shoyab M., Plowman G. D., McDonald V. L., Bradley J. G., Todaro G. J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science. 1989 Feb 24;243(4894 Pt 1):1074–1076. doi: 10.1126/science.2466334. [DOI] [PubMed] [Google Scholar]
  48. Shuster S. Psoriatic alopecia. Br J Dermatol. 1972 Jul;87(1):73–77. doi: 10.1111/j.1365-2133.1972.tb05103.x. [DOI] [PubMed] [Google Scholar]
  49. Stoll S., Garner W., Elder J. Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture. J Clin Invest. 1997 Sep 1;100(5):1271–1281. doi: 10.1172/JCI119641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Turksen K., Kupper T., Degenstein L., Williams I., Fuchs E. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5068–5072. doi: 10.1073/pnas.89.11.5068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Vassar R., Fuchs E. Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev. 1991 May;5(5):714–727. doi: 10.1101/gad.5.5.714. [DOI] [PubMed] [Google Scholar]
  52. Vassar R., Rosenberg M., Ross S., Tyner A., Fuchs E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci U S A. 1989 Mar;86(5):1563–1567. doi: 10.1073/pnas.86.5.1563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Williams I. R., Kupper T. S. Epidermal expression of intercellular adhesion molecule 1 is not a primary inducer of cutaneous inflammation in transgenic mice. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9710–9714. doi: 10.1073/pnas.91.21.9710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Williams I. R., Ort R. J., Kupper T. S. Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune response to cutaneous antigens. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12780–12784. doi: 10.1073/pnas.91.26.12780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wright A. L., Messenger A. G. Scarring alopecia in psoriasis. Acta Derm Venereol. 1990;70(2):156–159. [PubMed] [Google Scholar]
  56. Wrone-Smith T., Nickoloff B. J. Dermal injection of immunocytes induces psoriasis. J Clin Invest. 1996 Oct 15;98(8):1878–1887. doi: 10.1172/JCI118989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Yin J. A., Jowitt S. N. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant. 1992 Jan;9(1):31–33. [PubMed] [Google Scholar]
  58. Yokota A., Hukazawa M., Nakaseko C., Ishii A., Ikegami T., Kogure K., Nishimura M., Matsuura Y., Morio S., Nakamura H. [Resolution of psoriasis vulgaris following allogeneic bone marrow transplantation for aplastic anemia]. Rinsho Ketsueki. 1996 Jan;37(1):35–39. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES